The MetroHealth System Signs Deal with Global Med Technologies(R), Inc. for Transfusion Management System
December 07 2004 - 10:00AM
PR Newswire (US)
The MetroHealth System Signs Deal with Global Med Technologies(R),
Inc. for Transfusion Management System DENVER, Dec. 7
/PRNewswire-FirstCall/ -- Wyndgate Technologies(R) ("Wyndgate"), a
division of Global Med Technologies(R), Inc. (OTC:GLOB) (BULLETIN
BOARD: GLOB) ("Global Med" or the "Company"), announced the signing
of an agreement for SafeTrace Tx(R)*, its advanced transfusion
management with The MetroHealth System in Cleveland, Ohio. Terms of
the agreement were not disclosed. (Logo:
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO) "The
MetroHealth System is a very complex healthcare facility affiliated
with Case Western Reserve University School of Medicine, and we
needed a robust transfusion management system to manage the
complexities of our transfusion service operation," said Carol
Iaffaldano, Administrator, MetroHealth Department of Pathology. Ms.
Iaffaldano added, "The comprehensive safety features in SafeTrace
Tx and Wyndgate's extensive experience with installations in large
and multi-facility organizations were an integral part of the
reason that we selected Wyndgate to install its product in our
transfusion service." "We are delighted that The MetroHealth System
selected SafeTrace Tx to automate its transfusion service," said
Wm. Scott Dustin, Vice President of Sale and Marketing at Global
Med Technologies. Mr. Dustin added, "Our experience in the industry
as a provider of blood bank solutions and the quality of our
products are why our SafeTrace Tx advanced transfusion management
system is in use in over 150 transfusion services ranging in size
from small hospitals to large multi-facility healthcare networks as
well as regional centralized transfusion services." Our product
continues to gain recognition and acceptance as a leader in
transfusion medicine automation. About The MetroHealth System The
MetroHealth System is one of the nation's largest and most
successful public health care providers, offering health care for
the most critically injured trauma patients to skilled nursing care
for the chronically ill. Affiliated with Case Western Reserve
University since 1914, MetroHealth continues to build on its
long-standing teaching reputation and research excellence, offering
vital training and research opportunities for students and
physicians. MetroHealth conducts cutting-edge research in
biomedical sciences, particularly in the areas of cancer, heart,
liver and kidney research. For more information, go to:
http://www.metrohealth.org/. About Global Med Technologies, Inc.
Global Med Technologies, Inc. is an international e-Health, medical
information technology company, providing information management
software products and services to the healthcare industry. Its
Wyndgate Technologies division is a leading supplier of information
management systems to U.S. and international blood centers and
hospital transfusion centers. Current clients of Wyndgate's
products and services manage more than 3 million units of blood, or
over 22% of the U.S. blood supply, each year. Wyndgate's products
are also being implemented in Canada, the Caribbean and sub-Saharan
Africa. Together, the SafeTrace Tx advanced transfusion management
system and the SafeTrace(R) donor management system provide
Vein-to-Vein(R) tracking from donor collection to patient
transfusion. For more information about Global Med's products and
services, please call 800-WYNDGATE or visit
http://www.globalmedtech.com/, http://www.peoplemed.com/ and
http://www.wyndgate.com/. Press Inquiries: Investor Inquiries: Wm.
Scott Dustin Tom Marcinek Vice President of Sales and Marketing
President and COO 916-404-8415 916-404-8413 This news release may
include statements that constitute forward-looking statements,
usually containing the words "believe," "estimate," "project,"
"expects" or similar expressions. These statements are made
pursuant to the safe harbor provisions of the Private Securities
Litigation Reform Act of 1995. Forward-looking statements
inherently involve risks and uncertainties that could cause actual
results to differ materially from the forward-looking statements.
By making these forward-looking statements, the Company undertakes
no obligation to update these statements for revisions or changes
after the date of this news release. * Patent Pending
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO
http://photoarchive.ap.org/ DATASOURCE: Global Med Technologies,
Inc. CONTACT: Press, Wm. Scott Dustin, Vice President of Sales and
Marketing, +1-916-404-8415, , or Investors, Tom Marcinek, President
and COO, +1-916-404-8413, , both of Global Med Technologies, Inc.
Web site: http://www.metrohealth.org/ Web site:
http://www.globalmedtech.com/
Copyright